Endometriosis in adolescent: analysis of 4 cases

In: Beijing Medical Journal · 2007 · W2360961631
article OA: closed CC0
View on OpenAlex
AI-generated summary by qwen3.7-flash, 2026-08-24

This analysis of four adolescent endometriosis cases highlights dysmenorrhea and chronic pelvic pain as primary symptoms, noting that conservative surgery combined with medical therapy is an effective treatment approach for this condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To analysis the etiology, clinical features, diagnosis and treatment of adolescent endometriosis. Methods Four cases of adolescent with endometriosis (14~20 years old) treated in Peking University People's Hospital were reviewed. Results The frequency of adolescent endometriosis was about 2% (4/202). The chief symptoms leading to diagnosis were dysmenorrhea, chronic pelvic pain, pelvic mass and acute abdominal pain. Ovary was the most affected organ. Two patients had complicated genital tract anomalies. Conservative surgical therapies were performed in all patients, and medical therapies were followed for the advanced patients. Conclusions The main symptoms of adolescent endometriosis may not be typical, endometriosis should be strongly suspected in adolescent with chronic pelvic pain especially with no response to oral contraceptives and nonsteriodal anti-inflammatory medicine. The treatment of adolescent endometriosis can be conservative operation combined with medical therapy.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_paindysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK